CompletedNCT00314821
Official study titleA Randomized, Double-blind, Placebo-controlled Study of the Efficacy of Ropinirole in the Treatment of Depression in Bipolar Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including AtlantaBipolarity, DepressionMedication studyAges 18–64
- Countries
- United States
- Sponsor
- Cambridge Health Alliance
WithdrawnNCT00447096
Official study titlerTMS (Repetitive Transcranial Magnetic Stimulation) for Acute Treatment of Depressed Phase of Bipolar Disorder Type II
This study was withdrawn before enrollment.
In DallasBipolarity, DepressionDevice studyAges 18–65
- Countries
- United States
- Sponsor
- University of Texas Southwestern Medical Center
WithdrawnNCT00359125
Official study titleEfficacy of Mifepristone (RU-486) in the Treatment of Bipolar Depression.
This study was withdrawn before enrollment.
In VancouverBipolarity, DepressionMedication studyAges 19–65
- Countries
- Canada
- Sponsor
- University of British Columbia
CompletedNCT00852202
What is this study about?Researchers compared cariprazine and placebo to find out how the approaches affected depression symptoms in people with bipolarity during a depressive episode.
This study has finished and is no longer accepting participants.
Multiple locations, including EncinoBipolarity, DepressionMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Forest Laboratories
CompletedNCT00060489
Official study titleSafety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamBipolarity, DepressionMedication studyAges 18–65
- Countries
- United States
- Sponsor
- AstraZeneca
TerminatedNCT01122927
Official study titleA Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
This study ended early.
Multiple locations, including DothanBipolarity, SchizophreniaMedication studyAges 10–17
- Countries
- United States, Bulgaria, Croatia, + 10 others
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT01396447
What is this study about?Researchers compared Cariprazine and placebo to find out how the approaches affected depression symptoms in people with bipolarity during a depressive episode.
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamBipolarity, DepressionMedication studyAges 18–65
- Countries
- United States, Canada, Bulgaria, + 3 others
- Sponsor
- Forest Laboratories
CompletedNCT04211961
What is this study about?This study evaluated the safety and effectiveness of Scopolamine for people with bipolarity.
This study has finished and is no longer accepting participants.
In GalwayBipolarity, DepressionMedication studyAges 18+
- Countries
- Ireland
- Sponsor
- Dr. Brian Hallahan
CompletedNCT02253225
Official study titleAn fMRI Study of Self Processing and Self Focus in Major Depression and Bipolar Disorder
This study has finished and is no longer accepting participants.
In BostonBipolarity, DepressionObservational studyAges 18–64
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT02974010
Official study titleSequential Therapy (NRX-100 Followed by NRX-101) for the Treatment of Acute Suicidal Ideation and Behavior in Bipolar Depression: the STABIL-B Study
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamBipolarity, Depression, ...Medication studyAges 18–65
- Countries
- United States
- Sponsor
- NeuroRx, Inc.
TerminatedNCT01665950
Official study titleSimvastatin Augmentation of Lithium Treatment in Bipolar Depression
This study ended early.
In BostonBipolarity, DepressionMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
TerminatedNCT00229151
Official study titleSleep Deprivation and Three Days Sleep Phase Advancement as Treatment for Bipolar Depression.
This study ended early.
In TrondheimBipolarity, DepressionBehavioural studyAges 18+
- Countries
- Norway
- Sponsor
- Norwegian University of Science and Technology